VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,000 | -35.9% | 73,809 | -2.1% | 0.00% | – |
| Q2 2023 | $498,000 | +6.6% | 75,409 | +9.8% | 0.00% | – |
| Q1 2023 | $467,000 | +191.9% | 68,648 | +216.2% | 0.00% | – |
| Q4 2022 | $160,000 | -23.8% | 21,711 | +2.2% | 0.00% | – |
| Q3 2022 | $210,000 | -8.3% | 21,235 | +1.3% | 0.00% | – |
| Q2 2022 | $229,000 | -3.0% | 20,955 | +0.2% | 0.00% | – |
| Q1 2022 | $236,000 | -30.6% | 20,906 | -3.3% | 0.00% | – |
| Q4 2021 | $340,000 | -8.6% | 21,622 | -0.3% | 0.00% | – |
| Q3 2021 | $372,000 | -17.5% | 21,680 | +3.5% | 0.00% | – |
| Q2 2021 | $451,000 | +43.6% | 20,947 | +0.1% | 0.00% | – |
| Q1 2021 | $314,000 | -35.5% | 20,928 | -43.5% | 0.00% | – |
| Q4 2020 | $487,000 | +23.9% | 37,034 | -8.8% | 0.00% | – |
| Q3 2020 | $393,000 | -4.4% | 40,598 | +13.2% | 0.00% | – |
| Q2 2020 | $411,000 | +105.5% | 35,854 | +85.7% | 0.00% | – |
| Q1 2020 | $200,000 | +545.2% | 19,303 | +940.0% | 0.00% | – |
| Q4 2019 | $31,000 | +34.8% | 1,856 | +6.1% | 0.00% | – |
| Q3 2019 | $23,000 | -14.8% | 1,750 | -7.4% | 0.00% | – |
| Q2 2019 | $27,000 | -22.9% | 1,890 | -0.6% | 0.00% | – |
| Q1 2019 | $35,000 | -52.7% | 1,902 | -33.0% | 0.00% | – |
| Q4 2018 | $74,000 | +19.4% | 2,840 | +6.3% | 0.00% | – |
| Q3 2018 | $62,000 | +24.0% | 2,671 | +1.1% | 0.00% | – |
| Q2 2018 | $50,000 | -18.0% | 2,643 | -27.6% | 0.00% | – |
| Q1 2018 | $61,000 | +3.4% | 3,649 | -6.0% | 0.00% | – |
| Q4 2017 | $59,000 | -54.3% | 3,880 | -46.1% | 0.00% | – |
| Q3 2017 | $129,000 | +126.3% | 7,194 | +104.7% | 0.00% | – |
| Q2 2017 | $57,000 | +16.3% | 3,515 | +0.3% | 0.00% | – |
| Q1 2017 | $49,000 | -34.7% | 3,506 | -25.1% | 0.00% | – |
| Q4 2016 | $75,000 | +29.3% | 4,680 | +33.7% | 0.00% | – |
| Q3 2016 | $58,000 | +107.1% | 3,500 | +40.0% | 0.00% | – |
| Q2 2016 | $28,000 | -67.8% | 2,500 | -76.0% | 0.00% | – |
| Q1 2016 | $87,000 | -10.3% | 10,400 | -0.6% | 0.00% | – |
| Q4 2015 | $97,000 | -31.7% | 10,462 | -17.2% | 0.00% | – |
| Q3 2015 | $142,000 | +54.3% | 12,628 | +73.9% | 0.00% | – |
| Q2 2015 | $92,000 | +16.5% | 7,260 | -14.6% | 0.00% | – |
| Q1 2015 | $79,000 | -35.2% | 8,500 | 0.0% | 0.00% | – |
| Q4 2014 | $122,000 | +47.0% | 8,500 | +6.2% | 0.00% | – |
| Q3 2014 | $83,000 | -35.7% | 8,000 | 0.0% | 0.00% | – |
| Q2 2014 | $129,000 | +3.2% | 8,000 | +3.9% | 0.00% | – |
| Q1 2014 | $125,000 | +101.6% | 7,700 | +54.0% | 0.00% | – |
| Q4 2013 | $62,000 | -91.6% | 5,000 | -92.5% | 0.00% | -100.0% |
| Q3 2013 | $734,000 | +118.5% | 67,084 | +61.3% | 0.00% | – |
| Q2 2013 | $336,000 | – | 41,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |